Skip to main content

Table 2 The association between metabolic markers with NEAP and PRAL in T2DM patients

From: Dietary acid load modifies the effects of ApoA2–265 T > C polymorphism on lipid profile and serum leptin and ghrelin levels among type 2 diabetic patients

 

Tertile of NEAP

 

Tertile of PRAL

 
 

T1

T2

T3

Pa

T1

T2

T3

Pa

N

242

242

242

 

242

242

242

 

Age (year)

54.38 ± 6.29

53.77 ± 6.56

54.09 ± 6.89

0.59

54.45 ± 5.93

53.51 ± 6.97

54.26 ± 6.84

0.25

BMI (kg/m2)

29.39 ± 5.01

29.13 ± 4.44

29.53 ± 4.74

0.64

29.29 ± 4.67

29.32 ± 4.97

29.47 ± 4.55

0.90

WC (cm)

92.05 ± 11.27

91.60 ± 9.88

93.13 ± 10.54

0.26

91.47 ± 10.57

92.05 ± 10.80

93.29 ± 10.32

0.15

Physical activity (MET min/week)

38.09 ± 5.08

38.09 ± 5.58

37.14 ± 5.70

0.08

38.81 ± 5.7

37.27 ± 4.91

37.28 ± 5.62

0.002

Energy intake (kcal/day)

2403.72 ± 823.39

2457.27 ± 736.39

2710.80 ± 1084.58

< 0.001

2622.06 ± 876.52

2271.40 ± 693.04

2679.12 ± 1051.77

< 0.001

EER.(Men)

2548.14 ± 276.67

2553.32 ± 258.79

2635.04 ± 290.23

0.04

2553.65 ± 279.22

2552.15 ± 253.93

2631.33 ± 291.47

0.06

EER.(Women)

2010.66 ± 189.44

2016.83 ± 161.13

2038.14 ± 193.95

0.41

2008.6 ± 175.19

2018.46 ± 176.05

2040.61 ± 197.73

0.32

HDL-C (mg/dl)

54.76 ± 13.44

52.35 ± 12.59

52.68 ± 11.73

0.07

55.45 ± 13.81

51.59 ± 11.86

52.76 ± 11.86

0.003

LDL-C (mg/dl)

110.18 ± 37.86

106.72 ± 35.41

105.96 ± 32.16

0.37

111.14 ± 39.10

105.39 ± 33.97

106.89 ± 32.88

0.18

TC (mg/dl)

195.70 ± 68.43

203.88 ± 75.79

197.76 ± 77.63

0.45

197.38 ± 70.67

200.93 ± 73.10

199.27 ± 78.34

0.87

TG (mg/dl)

184.54 ± 107.98

185.52 ± 106.84

185.97 ± 108.05

0.98

190.78 ± 109.63

177.41 ± 100.91

187.39 ± 111.41

0.37

Leptin (ng/ml)

25.76 ± 13.61

25.48 ± 14.75

23.16 ± 15.26

0.48

25.54 ± 13.52

25.38 ± 15.49

23.56 ± 14.55

0.65

Ghrelin (ng/ml)

2.32 ± 1.02

2.32 ± 1.44

2.44 ± 1.47

0.83

2.16 ± 0.95

2.51 ± 1.45

2.42 ± 1.54

0.18

hs-CRP (mg/L)

2.31 ± 1.41

2.18 ± 1.59

2.24 ± 1.52

0.09

2.20 ± 1.41

2.28 ± 1.57

2.26 ± 1.52

0.96

PTX3(ng/ml)

2.6 ± 0.48

2.66 ± 0.46

2.60 ± 0.49

0.72

2.56 ± 0.51

2.67 ± 0.44

2.61 ± 0.47

0.47

IL18(pg/ml)

250.74 ± 37.67

245.75 ± 26.09

250.69 ± 27.55

0.61

248.61 ± 37.47

247.30 ± 27.18

250.55 ± 28.07

0.84

TAC(g/dl)

2.55 ± 0.53

2.45 ± 0.58

2.44 ± 0.56

0.54

2.61 ± 0.59

2.41 ± 0.52

2.42 ± 0.56

0.13

SOD(U/ml)

0.14 ± 0.03

0.14 ± 0.04

0.15 ± 0.04

0.40

0.14 ± 0.03

0.13 ± 0.04

0.15 ± 0.04

0.34

PGF2α(pg/ml)

72.83 ± 6.05

73.25 ± 5.76

71.39 ± 6.56

0.25

72.80 ± 6.02

73.21 ± 5.85

71.46 ± 6.48

0.28

AIP

0.48 ± 0.24

0.49 ± 0.25

0.49 ± 0.25

0.74

0.49 ± 0.23

0.48 ± 0.24

0.49 ± 0.26

0.98

AC

2.75 ± 1.59

3.07 ± 1.82

2.91 ± 1.70

0.13

2.75 ± 1.66

3.06 ± 1.74

2.93 ± 1.71

0.14

CRI.II

2.06 ± 0.68

2.09 ± 0.67

2.06 ± 0.64

0.88

2.05 ± 0.7

2.09 ± 0.66

2.08 ± 0.64

0.85

CRI

3.75 ± 1.59

4.07 ± 1.82

3.91 ± 1.70

0.13

3.75 ± 1.66

4.06 ± 1.74

3.93 ± 1.71

0.14

  1. Data are presented as mean ± standard deviation (SD). Abbreviation: PRAL Potential renal acid load, NEAP Net endogenous acid production, BMI Body mass index, WC Waist circumference, HDL-C High density lipoprotein cholesterol, LDL-C Low density lipoprotein cholesterol, CH Cholesterol, TG Triglyceride, hs-CRP High sensivity C-reactive protein, PTX3 Pentraxin 3, IL18 Interleukin 18, TAC Total antioxidant capacity, SOD Superoxide dismutase, PGF2α ProstaglandinF2α. Atherogenic Index of Plasma (AIP) = log (TG/HDL-C), Atherogenic Coefficient (AC) = (TC-HDL-C)/HDL-C, Castelli’s Risk Index II (CRI-II) = (LDL/HDL), Castelli’s Risk Index I (CRI-I) = (TC/HDL-C) a Obtained from ANOVA